Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kumar Prabhash

Showing results (1-10 of 469) with videos related to

Pageof 47
Sort By:
South Asian Journal of Cancer|February 16, 2019
Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line - Indian consensus statement updateKumar Prabhash
Journal of Oncology Practice|October 4, 2017
Evolving Management Strategies and Controversies in Early-Stage Lung CancerVanita Noronha, Kumar Prabhash
South Asian Journal of Cancer|January 24, 2014
The cure for a racing heartVanita Noronha, Kumar Prabhash
JAMA Oncology|November 4, 2021
Analysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non-Small Cell Lung CancerAkhil Kapoor, Kumar Prabhash
The Journal of the Association of Physicians of India|November 14, 2015
Role of Pneumococcal Vaccination in Oncology PatientsKumar Prabhash, Vanita Noronha, Amit Joshi
JAMA Oncology|January 27, 2018
Assessing Metronomic Chemotherapy for Progressive Pediatric Solid Malignant TumorsShripad Banavali, Kumar Prabhash, Vijay Patil
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|February 12, 2014
Chronic myeloid leukemia data from IndiaShweta Bansal, Kumar Prabhash, Purvish Parikh
South Asian Journal of Cancer|January 24, 2014
The changing landscape of hormonal therapy in castration-resistant prostate cancerAmol Dongre, Kumar Prabhash, Vanita Noronha
South Asian Journal of Cancer|January 24, 2014
Confusion worse confoundedVanita Noronha, Amit Joshi, Kumar Prabhash
JCO Global Oncology|July 23, 2025
Reply to: Critical Review: Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck CancerKumar Prabhash, Roshan Pawar, Vijaya Gunjal
Pageof 47

Showing results (1-10 of 469) with videos related to

Sort By:
Pageof 47
South Asian Journal of Cancer|February 16, 2019
Treatment of advanced nonsmall cell lung cancer: First line, maintenance and second line - Indian consensus statement updateKumar Prabhash
Journal of Oncology Practice|October 4, 2017
Evolving Management Strategies and Controversies in Early-Stage Lung CancerVanita Noronha, Kumar Prabhash
South Asian Journal of Cancer|January 24, 2014
The cure for a racing heartVanita Noronha, Kumar Prabhash
JAMA Oncology|November 4, 2021
Analysis of Outcomes With Addition of Immunotherapy to Chemoradiation Therapy for Non-Small Cell Lung CancerAkhil Kapoor, Kumar Prabhash
The Journal of the Association of Physicians of India|November 14, 2015
Role of Pneumococcal Vaccination in Oncology PatientsKumar Prabhash, Vanita Noronha, Amit Joshi
JAMA Oncology|January 27, 2018
Assessing Metronomic Chemotherapy for Progressive Pediatric Solid Malignant TumorsShripad Banavali, Kumar Prabhash, Vijay Patil
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|February 12, 2014
Chronic myeloid leukemia data from IndiaShweta Bansal, Kumar Prabhash, Purvish Parikh
South Asian Journal of Cancer|January 24, 2014
The changing landscape of hormonal therapy in castration-resistant prostate cancerAmol Dongre, Kumar Prabhash, Vanita Noronha
South Asian Journal of Cancer|January 24, 2014
Confusion worse confoundedVanita Noronha, Amit Joshi, Kumar Prabhash
JCO Global Oncology|July 23, 2025
Reply to: Critical Review: Efficacy and Safety of Biosimilar Cetuximab Versus Innovator Cetuximab in Indian Patients With Head and Neck CancerKumar Prabhash, Roshan Pawar, Vijaya Gunjal
Pageof 47